ClinicalTrials.govpublic full text
Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol
kidney failure, secondary hyperparathyroidism, hyperphosphatemia, hypercalcemia, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 811743
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.